Amylyx Pharmaceuticals, Inc. (AMLX)
Healthcare • Drug Manufacturers - Specialty & Generic
StockNasdaqGSUnited StatesUS03237H1014
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Amylyx Pharmaceuticals, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:13. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Mar 2027 08:00 | -0.37 | — | — | Upcoming |
| 05 Nov 2026 07:00 | -0.37 | -0.38 | -2.2% | Miss |
| 06 Aug 2026 07:00 | -0.36 | -0.39 | -9.0% | Miss |
| 07 May 2026 07:00 | -0.34 | -0.37 | -8.7% | Miss |
| 03 Mar 2026 07:00 | -0.34 | -0.30 | +12.2% | Beat |
| 06 Nov 2025 07:00 | -0.43 | -0.37 | +13.9% | Beat |
| 07 Aug 2025 07:00 | -0.45 | -0.46 | -1.2% | Miss |
| 08 May 2025 07:00 | -0.50 | -0.42 | +16.0% | Beat |
| 04 Mar 2025 06:00 | -0.59 | -0.55 | +6.8% | Beat |
| 07 Nov 2024 07:00 | -0.91 | -1.07 | -16.9% | Miss |
| 08 Aug 2024 07:00 | -0.82 | -0.62 | +23.9% | Beat |
| 09 May 2024 07:00 | -0.01 | -0.12 | -1,946.5% | Miss |
| 22 Feb 2024 07:00 | 0.23 | 0.07 | -69.3% | Miss |
| 09 Nov 2023 06:00 | 0.44 | 0.30 | -31.3% | Miss |
| 10 Aug 2023 16:00 | 0.07 | 0.31 | +342.9% | Beat |
| 11 May 2023 16:00 | -0.25 | 0.02 | +108.1% | Beat |
| 13 Mar 2023 16:00 | -0.84 | -0.65 | +22.8% | Beat |
| 10 Nov 2022 16:00 | -0.98 | -0.92 | +5.7% | Beat |
| 11 Aug 2022 16:00 | -0.84 | -0.93 | -10.3% | Miss |
| 12 May 2022 16:00 | -0.69 | -0.93 | -34.8% | Miss |
| 31 Mar 2022 14:00 | -0.64 | -4.15 | -548.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 0 | -100.0% | -144.7M | — | -1.53 | +65.5% | -123.5M |
| 2024 | 87.4M | -77.1% | -301.7M | -345.4% | -4.43 | -732.9% | -167.8M |
| 2023 | 380.8M | +1,612.9% | 49.3M | 12.9% | 0.70 | +120.6% | 10.7M |
| 2022 | 22.2M | — | -198.4M | -892.4% | -3.39 | — | -182.4M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 31.43 | 31.57 | 30.10 | 30.25 | -4.89% | 918,203 | |
| 11 Nov 2026 | 31.16 | 31.88 | 30.46 | 31.80 | +2.88% | 2,001,200 | |
| 10 Nov 2026 | 29.94 | 31.22 | 29.76 | 30.91 | +2.32% | 1,424,800 | |
| 09 Nov 2026 | 29.85 | 30.32 | 28.76 | 30.21 | +2.41% | 1,297,600 | |
| 06 Nov 2026 | 27.73 | 29.58 | 27.50 | 29.50 | +6.81% | 1,860,500 | |
| 05 Nov 2026 | 30.23 | 30.23 | 27.48 | 27.62 | -6.05% | 2,210,100 | |
| 04 Nov 2026 | 30.65 | 30.67 | 27.90 | 29.40 | +0.68% | 1,586,300 | |
| 03 Nov 2026 | 28.52 | 29.46 | 28.21 | 29.20 | +4.14% | 1,202,700 | |
| 02 Nov 2026 | 28.84 | 29.50 | 27.62 | 28.04 | -2.84% | 1,161,800 | |
| 30 Oct 2026 | 28.41 | 29.09 | 28.00 | 28.86 | +0.63% | 989,500 | |
| 1,207 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $39 (opens in a new tab) Benzinga · 10 Nov 2026 13:36
- Why Amylyx Pharmaceuticals Stock Is Up 6.8% And What's Next (opens in a new tab) Simply Wall St. · 08 Nov 2026 04:27
- Amylyx Pharmaceuticals (AMLX) Stock Looks Pricey After Positive Phase 3 Results (opens in a new tab) Simply Wall St. · 07 Nov 2026 23:12
- Amylyx Pharmaceuticals (AMLX) Posts Positive Phase 3 Data, Is The 30% Discount Justified? (opens in a new tab) Simply Wall St. · 07 Nov 2026 21:15
- Amylyx Pharmaceuticals Inc (AMLX) Q3 2026 Earnings Call Highlights: $768 Million Cash Position ... (opens in a new tab) GuruFocus.com · 07 Nov 2026 19:06
- Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 09:14
- Amylyx Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 23:52
- Amylyx (AMLX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 19:16
- Amylyx Pharmaceuticals Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 17:14
- Amylyx Pharmaceuticals Reports Third Quarter 2026 Financial Results (opens in a new tab) 05 Nov 2026 12:00
- Amylyx Pharma Q3 EPS $(0.38), Inline (opens in a new tab) Benzinga · 05 Nov 2026 08:00
- Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts (opens in a new tab) 04 Nov 2026 14:00
- Amylyx Pharmaceuticals to Participate in Upcoming November Investor Conferences (opens in a new tab) 03 Nov 2026 14:00
- Amylyx Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026 (opens in a new tab) 02 Nov 2026 14:00
- Amylyx Pharmaceuticals And 2 More Quality Growth Stocks (opens in a new tab) Simply Wall St. · 04 Oct 2026 08:09
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 31.80 USD
- Market cap
- 3.9B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow AMLX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.